Esthesioneuroblastoma is a rare disease that requires multi-institutional and international collaboration. An interprofessional team approach provides the best outcomes. Centralized processing of esthesioneuroblastoma cases would offer the most favorable ground to accrue more patients and use a uniform database in collecting information and reporting outcomes.